Better High-Yield Dividend Stock: Pfizer or Novo Nordisk?
Better High-Yield Dividend Stock: Pfizer or Novo Nordisk? The Globe and Mail
Covered in this story
What has happened since
- Pfizer is up 0.0% since this was published.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Pfizer
- HSBC: $23.7 → $28 by Jul 2027 · Hold via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $PFE yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Pfizer →Also covered by 1 other outlet
Dalsna Finance is currently tracking 48 stories mentioning Pfizer, the earliest published 22 May 2026.
Summary aggregated from The Globe and Mail's public RSS feed. The full reporting belongs to The Globe and Mail — please read it on their site.